Welcome to ORVEX biomedical research.
Research Area: Neurobiology & Cognitive Research
Semax is a synthetic heptapeptide derived from the C-terminal sequence of ACTH(4–10), with the amino acid sequence Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP). It is extensively studied in experimental neuroscience in relation to neurotrophic signaling, neuronal responses, neurotransmitter-associated pathways, and cognitive research models.
Supplied as a lyophilized powder for qualified laboratory research and intended exclusively for in vitro and analytical studies involving neuropeptide signaling, cellular responses, neurotrophic pathways, and experimental neurobiology.
Storage: Store according to validated laboratory and supplier specifications, protected from excessive heat, moisture, and direct light.
FOR RESEARCH USE ONLY. Not intended for human or veterinary use.
$40.00
Research Area: Neurobiology & Cognitive Research
Semax is a synthetic heptapeptide derived from the C-terminal ACTH(4–10) sequence. Its amino acid sequence is Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP). Semax has been investigated extensively in experimental neuroscience, with research focusing on neuropeptide signaling, neurotrophic pathways, neuronal responses, and cognitive-related mechanisms.
Semax provides a defined synthetic peptide model for laboratory studies involving neuronal signaling and neurobiological processes. Experimental research has investigated its relationship with neurotrophic factors, neurotransmitter systems, oxidative stress, and cellular responses in various experimental models.
Semax is supplied as a lyophilized powder for qualified laboratory research and is intended exclusively for in vitro, analytical, and non-clinical research applications.
Semax is a synthetic ACTH(4–10)-derived heptapeptide with the sequence MEHFPGP. It should be distinguished from full-length adrenocorticotropic hormone (ACTH) and from other synthetic ACTH-derived peptide analogs or modified derivatives.
The product described here refers specifically to the Semax peptide sequence used in experimental research.
Semax may be used as a research material in studies involving:
Semax was developed as a synthetic peptide derived from the ACTH(4–10) sequence and has subsequently been investigated in experimental neuroscience. Research has examined its effects on neurotrophic signaling and neuronal responses, including pathways associated with brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF).
The peptide has also been investigated in experimental models involving neurotransmitter regulation, stress-related neuronal responses, and cognitive processes. These studies provide a basis for continued investigation of Semax as a molecular research tool in neurobiology.
One important area of Semax research involves neurotrophic signaling. Experimental studies have investigated changes in the expression or activity of neurotrophic factors such as BDNF and NGF, which are involved in neuronal maintenance, differentiation, synaptic plasticity, and cellular signaling.
These pathways provide experimental models for examining how synthetic neuropeptides may interact with cellular mechanisms involved in neuronal function and adaptation.
Semax has also been investigated in experimental models examining neurotransmitter-associated processes, including dopaminergic and serotonergic signaling. Such research provides opportunities to study the relationship between neuropeptide signaling and neuronal communication.
Cognitive and behavioral models have been used to investigate Semax-related biological responses under controlled experimental conditions. These findings remain primarily experimental and should not be interpreted as established clinical effects.
Additional research has investigated Semax in experimental models involving oxidative stress and neuronal cellular responses. These studies examine interactions between peptide exposure, reactive oxygen species, metal-associated processes, and cellular signaling.
This area contributes to broader research into molecular mechanisms involved in neuronal stress and neurodegenerative disease models.
| Compound Name | Semax |
|---|---|
| Synonyms | Semax; ACTH(4–10) Pro-Gly-Pro analog |
| Peptide Class | Synthetic Neuropeptide |
| Sequence | MEHFPGP |
| Sequence Length | 7 amino acids |
| Form | Lyophilized Powder |
| Net Content | 10mg per vial |
| Purity | ≥99% HPLC where applicable |
| Molecular Formula | C37H51N9O10 |
| Molecular Weight | 813.88 g/mol |
| Application | In vitro and analytical research only |
FOR RESEARCH USE ONLY.
Semax is supplied as a research material for qualified laboratory use and is not intended for human or veterinary administration. Biological effects described in the literature are based primarily on experimental and preclinical research and should not be interpreted as established therapeutic claims.
Orvexbio Research Transparency is essential. Every batch undergoes independent third-party testing in the USA, with Certificates of Analysis (COAs) readily available for verification, providing researchers with confidence in the quality and consistency of their work.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Added to cart
Check out our shop to see what's available